NewAmsterdam Pharma Soars 41% On A Surprise Benefit From Cholesterol Drug
NewAmsterdam Pharma Soars 41% On A Surprise Benefit From Cholesterol Drug · Investor's Business Daily

In This Article:

NewAmsterdam Pharma said Tuesday its cholesterol drug lowered the risk of major cardiovascular events and the biotech stock catapulted.